Glow LifeTechGLWLF 3-Year RORE % is 0.00 as of Mar. 2026. The stock has 1 warning sign investors should review. Among 1,289 Biotechnology companies, Glow LifeTech ranks worse than 77579.44% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Glow LifeTech's 3-Year RORE % for the quarter that ended in Mar. 2026 was 0.00%.
The industry rank for Glow LifeTech's 3-Year RORE % or its related term are showing as below:
GLWLF's 3-Year RORE % is not ranked *
in the Biotechnology industry.
Industry Median: -11.53 * Ranked among companies with meaningful 3-Year RORE % only.
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Glow LifeTech 3-Year RORE % Related Terms
Glow LifeTech 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Glow LifeTech's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GLWLF vs VRTX, REGN, ALNY: 3-Year RORE % Comparison
For the Biotechnology subindustry, Glow LifeTech's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glow LifeTech 3-Year RORE % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Glow LifeTech's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Glow LifeTech's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Glow LifeTech (GLWLF) has a 3-Year RORE % of 0.00 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Glow LifeTech and its competitors. According to the industry distribution chart, Glow LifeTech ranks #999999 out of 1289 companies in the Biotechnology industry.
Is Glow LifeTech's 3-Year RORE % too high?
Glow LifeTech's current 3-Year RORE % is 0.00. Based on the distribution chart, Glow LifeTech ranks #999999 out of 1289 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Glow LifeTech's 3-Year RORE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Glow LifeTech ranks #999999 out of 1289 companies for 3-Year RORE %. This places Glow LifeTech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Biotechnology company?
A good 3-Year RORE % depends on the Biotechnology industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Glow LifeTech and its competitors. Glow LifeTech's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glow LifeTech stock overvalued right now?
Glow LifeTech (GLWLF) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Glow LifeTech (GLWLF), the current 3-Year RORE % is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Glow LifeTech Corp is a biotechnology company engaged in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLWLF has been successfully added to your 